Pfizer Vaccine Prevents 90% of Infections in Large Study

Nov.09 — The Covid-19 vaccine under development by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a trial involving tens of thousands of volunteers. Bloomberg Intelligence’s Sam Fazeli has the details on “Bloomberg Surveillance.”

Watch the video at Bloomberg – Corona Outbreak